Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6701217 | 7377366 | I | 6701217-3 | 20060601 | 20100413 | 20100427 | EXP | TUK2010A00014 | TAKEDA PHARMACEUTICALS NORTH AMERICA | 72 | YR | F | N | 20100426 | UNITED KINGDOM |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6701217 | 1013588483 | PS | ACTOS | 1 | 30 MG (1 IN 1 D) | Y | 21073 | ||||
| 6701217 | 1013626476 | SS | SUPRALIP (FENOFIBRATE) | 2 | 160 MG (1 IN 1 D) | ||||||
| 6701217 | 1013627789 | SS | ROSIGLITAZONE | 1 | 4 MG (1 IN 1 D), 8 MG (1 IN 1 D) | ||||||
| 6701217 | 1013627791 | SS | SIMVASTATIN | 1 | ORAL | ORAL | |||||
| 6701217 | 1013627793 | SS | ATORVASTATIN CALCIUM | 1 | |||||||
| 6701217 | 1013627794 | SS | ROSUVASTATIN (ROSUVASTATIN) | 2 | |||||||
| 6701217 | 1013627795 | SS | METFORMIN HCL | 1 | |||||||
| 6701217 | 1013627828 | C | ROSUVASTATIN (ROSUVASTATIN) | 2 | |||||||
| 6701217 | 1013627829 | C | METFORMIN HCL | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6701217 | 1013588483 | TYPE 2 DIABETES MELLITUS |
| 6701217 | 1013626476 | DRUG USE FOR UNKNOWN INDICATION |
| 6701217 | 1013627789 | TYPE 2 DIABETES MELLITUS |
| 6701217 | 1013627791 | TYPE 2 DIABETES MELLITUS |
| 6701217 | 1013627793 | DRUG USE FOR UNKNOWN INDICATION |
| 6701217 | 1013627794 | DRUG USE FOR UNKNOWN INDICATION |
| 6701217 | 1013627795 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6701217 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6701217 | DIABETES MELLITUS INADEQUATE CONTROL |
| 6701217 | HIGH DENSITY LIPOPROTEIN DECREASED |
| 6701217 | INSULIN RESISTANCE |
| 6701217 | MYALGIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6701217 | HP |
| 6701217 | LIT |
| 6701217 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6701217 | 1013588483 | 20070201 | 20070501 | 3 | MON |
| 6701217 | 1013626476 | 20030501 | 20060901 | ||
| 6701217 | 1013626476 | 20060901 | |||
| 6701217 | 1013627789 | 20050301 | 20050601 | 3 | MON |
| 6701217 | 1013627789 | 20050601 | 20060901 | 15 | MON |
| 6701217 | 1013627794 | 2 | MON | ||
| 6701217 | 1013627794 | 40 | MON |